1Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, Yangzhou, China
2Department of Radiology, Northern Jiangsu People’s Hospital, Yangzhou, China
3Northern Jiangsu People’s Hospital, Yangzhou, China
4MR Research China, GE Healthcare, Beijing, China
5Northwestern University, Chicago, United States of America
6GE Healthcare, Beijing, China
Presenting Author: Xinyu Feng
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Breast Cancer Association Consortium, Dorling L, Carvalho S, et al. Breast cancer risk genes - association analysis in more than 113,000 women. N Engl J Med. 2021;384(5):428-439. doi:10.1056/NEJMoa1913948 [doi]
2. Zhu G, Dong Y, Zhu R, et al. Dynamic contrast-enhanced magnetic resonance imaging parameters combined with diffusion-weighted imaging for discriminating malignant lesions, molecular subtypes, and pathological grades in invasive ductal carcinoma patients. PloS One. 2025;20(4):e0320240. doi:10.1371/journal.pone.0320240 [doi]
3. Karahaliou A, Vassiou K, Arikidis NS, Skiadopoulos S, Kanavou T, Costaridou L. Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis. Br J Radiol. 2010;83(988):296-309. doi:10.1259/bjr/50743919 [doi]
4. Liu L, Mei N, Yin B, Peng W. Correlation of DCE-MRI perfusion parameters and molecular biology of breast infiltrating ductal carcinoma. Front Oncol. 2021;11:561735-561743. doi:10.3389/fonc.2021.561735 [doi]
5. Lv W, Zheng D, Guan W, Wu P. Contribution of diffusion-weighted imaging and ADC values to papillary breast lesions. Front Oncol. 2022;12:911790-911798. doi:10.3389/fonc.2022.911790 [doi]